The possibility of neoplastic transformation of ovarian endometriosis
- Autores: Gromova T.A.1, Sheshukova N.A.1, Bolshakova O.V.2, Zairatyants O.V.3, Levakov S.A.1, Fedotov E.V.4
-
Afiliações:
- I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
- Bakhrushins Brothers City Clinical Hospital, Moscow Healthcare Department
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
- A.K. Eramishantsev City Clinical Hospital, Moscow Healthcare Department
- Edição: Nº 3 (2018)
- Páginas: 96-101
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/248201
- DOI: https://doi.org/10.18565/aig.2018.3.96-101
- ID: 248201
Citar
Texto integral
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
Texto integral
Sobre autores
Tatyana Gromova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Email: tgromova928@yandex.ru
post-graduate student of the Department of Obstetrics and Gynecology of the Faculty of Medicine
Natalia Sheshukova
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Email: dr.sheshukova@mail.ru
MD, Professor of the Department of Obstetrics and Gynecology of the Faculty of Physiology
Olesya Bolshakova
Bakhrushins Brothers City Clinical Hospital, Moscow Healthcare DepartmentCandidate of Medical Sciences, Head of the gynecological department
Oleg Zairatyants
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
Email: ovzair@mail.ru
MD, professor, head of the Department of Pathological Anatomy
Sergey Levakov
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia
Email: levakoff@yandex.ru
MD, Professor, Head of the Department of Obstetrics and Gynecology of the Medical Faculty
Evgeniy Fedotov
A.K. Eramishantsev City Clinical Hospital, Moscow Healthcare DepartmentCandidate of Medical Science, Head of the pathoanatomical department
Bibliografia
- Jiang Q.Y., Wu R.J. Growth mechanisms of endometriotic cells in implanted places: a review. Gynecol. Endocrinol. 2012; 28(7): 562-7. doi: 10.3109/09513590.2011.650662.
- Леваков С.А., Громова Т.А., Кедрова А.Г., Шешукова Н.А. Эндометриозассоциированный рак яичников. Опухоли женской репродуктивной системы. 2016; 12(4): 47-51.
- Pearce C.L., Templeman C., Rossing M.A., Lee A., Near A.M., Webb P.M. et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet 0ncol. 2012; 13(4): 385-94. doi: 10.1016/S1470-2045(11)70404-1.
- Krawczyk N., Banys-Paluchowski M., Schmidt D., Ulrich U., Fehm T. Endometriosis-associated malignancy. Geburtshilfe Frauenheilkd. 2016; 76(2): 176-81. doi: 10.1055/s-0035-1558239.
- Yu H.C., Lin C.Y., Chang W.C., Shen B.J., Chang WP, Chuang C.M. et al. Increased association between endometriosis and endometrial cancer: a nationwide population-based retrospective cohort study. Int. J. Gynecol. Cancer. 2015; 25(3): 447-52. doi: 10.1097/IGC.0000000000000384.
- Amano Y., Mandai M., Yamaguchi K., Matsumura N., Kharma B., Baba T. et al. Metabolic alterations caused by HNF1ß expression in ovarian clear cell carcinoma contribute to cell survival. Oncotarget. 2015; 6(28): 26002-17. doi: 10.18632/oncotarget.4692.
- Mandai M., Amano Y., Yamaguchi K., Matsumura N., Baba T., Konishi I. Ovarian clear cell carcinoma meets metabolism; HNF-1ß confers survival benefits through the Warburg effect and ROS reduction. Oncotarget. 2015; 6(31): 30704 14. doi: 10.18632/oncotarget.5228
- Suzuki E., Kajita S., Takahashi H., Matsumoto T., Tsuruta T., Saegusa M. Transcriptional upregulation of HNF-1ß by NF-kB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression. Lab. Invest. 2015; 95(8): 962-72. doi: 10.1038/ labinvest.2015.73.
- DeLair D., Han G., Irving J.A., Leung S., Ewanowich C.A., Longacre T.A. et al. HNF-1ß in ovarian carcinomas with serous and clear cell change. Int. J. Gynecol. Pathol. 2013; 32(6): 541-6. doi: 10.1097/PGP.0b013e318273fd07.
- Hoang L.N., Han G., McConechy M., Lau S., Chow C., Gilks C.B. et al. Immunohistochemical characterization of prototypical endometrial clear cell carcinoma-diagnostic utility of HNF-1ß and oestrogen receptor. Histopathology. 2014; 64(4): 585-96. doi: 10.1111/his.12286.
- Kao Y.C., Lin M.C., Lin W.C., Jeng Y.M., Mao T.L. Utility of hepatocyte nuclear factor-1ß as a diagnostic marker in ovarian carcinomas with clear cells. Histopathology. 2012; 61(5): 760-8. doi: 10.1111/ j.1365-2559.2012.04267.x.
- Kurman R.J., Ellenson H., Ronnett L., Brigitte M., eds. Blaustein’s pathology of the female genital tract. 6th ed. Springer; 2011.
- Kurman R.J., Carcanglu M.L., Herrington C.S., Young R.H., eds. WHO classification of tumours of female reproductive organs. 4th ed. Lyon: WHO Press; 2014.
- Zaino R., Carinelli S.G., Ellenson L.H. Tumours of the uterine corpus: epithelial tumours and precursors. Lyon: WHOPress; 2014: 125-6.
- Brinkmann V., Abu Abed U., Goosmann C., Zychlinsky A. Immunodetection of NETs in paraffin-embedded tissue. Front. Immunol. 2016; 7: 513. eCollection 2016.
- Mojiri A., Stoletov K., Carrillo M.A., Willetts L., Jain S., Godbout R. et al. Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin. Oncotarget. 2017; 8(8): 13015-29. doi: 10.18632/ oncotarget.14273.
- Cohen D.A., Dabbs D.J., Cooper K.L., Amin M., Jones T.E., Jones M.W. et al. Interobserver agreement among pathologists for semiquantitative hormone receptor scoring in breast carcinoma. Am. J. Clin. Pathol. 2012; 138(6): 796-802. doi: 10.1309/AJCP6DKRND5CKVDD.
- Клинические рекомендации «Эндометриоз: диагностика, лечение и реабилитация». М.; 2013.
- Зайратьянц О.В., Адамян Л.В., Андреева Е.Н., Максимова Ю.В., Мурдалова З.Х., Опаленов К.В., Мовтаева Х.Р., Сонова М.М., Зарубина И.П. Молекулярно-биологические особенности эктопического и эутопического эндометрия при генитальном эндометриозе. Архив патологии. 2010; 72(5): 6-12.